RxDoctor Payments Data

Carolyn Freeman, NP

Psychiatric/Mental Health · Dresden, TNNPI 1326078973

Payments from drug & device makers

$5,209in general payments, 2019–2025

Across 301 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • AbbVie$786
  • Neurocrine Biosciences, Inc.$642
  • Otsuka America Pharmaceutical, Inc.$511
  • Alkermes, Inc.$453
  • Johnson & Johnson$276
  • plus $839 from 8 others

What the payments were for

  • Food & beverage$5,15099%
  • Education$591%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,209 in reported general payments places this provider in the 90th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$21,431
Medicare patients
106
Services billed
493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl192$279,180
IngrezzaValbenazine Tosylate25$209,697
CaplytaLumateperone Tosylate40$70,148
RexultiBrexpiprazole35$49,265
TrintellixVortioxetine Hydrobromide61$36,750
Lurasidone Hcl128$28,451
Risperidone ErRisperidone Microspheres17$24,435
Aripiprazole204$12,989
Paliperidone ErPaliperidone24$7,659
LamictalLamotrigine12$6,253
Buspirone Hcl471$5,398
Clozapine84$5,231
Quetiapine Fumarate309$4,735
Trazodone Hcl556$4,691
Oxcarbazepine88$4,607

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$786$279,180192 claims
Neurocrine Biosciences, Inc.Ingrezza$642$209,69725 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$1,701$70,14840 claims
Otsuka America Pharmaceutical, Inc.Rexulti$511$49,26535 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$196$36,75061 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Dresden

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →